Prevention and Early Diagnosis

Do you work in prevention and/or early diagnosis of skin cancer and other skin conditions?

This category recognises the impact of measurable preventative initiatives to help people, their families and/or carers to live healthier lives and reduce the risk of developing skin cancer and other skin conditions, and of early diagnosis and management initiatives to optimise outcomes and reduce complications.

Entries may be submitted by NHS organisations, charities, national bodies, CCGs, local authorities, schools, pharmacies and private/consumer brand initiatives operating at a local, regional or national level.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, along with details of project planning, methods, safety considerations, effectiveness, user feedback, cost efficiency and economic viability, as well as evidence of potential/demonstrable sustainability and dissemination.

Entries could include:

GP practice initiatives
Prevention of skin cancer initiatives
Early diagnosis of skin lesions, malignant and non-malignant
Early diagnosis of COVID-19, identification and management of skin rashes
Prevention of dermatitis and atopic dermatitis, early detection of symptoms and treatment to prevention complications
Early diagnosis and treatment of psoriasis
Digital and technology initiatives: should be UK or Ireland based (even if they are used globally).

Judging criteria and points. The judges will be focusing on the following areas when scoring your entry. Write your entry accordingly.
Summary: Provide background & brief overview of the initiative.	5
Innovation: Demonstrate evidence of innovation: what is new and different about your initiative, e.g. novel approaches, creative solutions to longstanding problems, bridging gaps in care etc.	15
Project planning: Describe the identified need for the initiative. Organisation, stakeholders, planned time frames and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?	10
Methods: Putting plans into action. What did you do? Describe how the initiative was implemented and outline the procedures and tools you used to measure outcomes.	10
Safety considerations: Risk assessment, clinical governance, ethics and any other safety considerations and how these were successfully addressed. Where applicable demonstrate adapting delivery of care with COVID-19.	15
Effectiveness: Demonstrate project effectiveness to illustrate efficiency improvement(s), how the initiative brought about change to support improved outcomes and what was the impact for people with skin conditions.	10
User feedback: Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and/or service users. Please include statements. Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.	10
Cost efficiency and economic viability: Evidence of, and maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.	10
Sustainability and evidence for sharing practice and dissemination: Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders and funding sources For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones For achieved spread of initiative to wider geographical areas or other healthcare setting include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.	15
Remember: entries without results will not be judged

in association with

QiC Dermatology is partnered by:

Supported by:

2021 KEY DATES
Open for entry: 16 November 2020
Extended Nomination Deadline: Monday 3 May 2021
Judging day: 27 May 2021
Awards ceremony: 09 September 2021